Elafin, an Elastase-specific Inhibitor, Is Cleaved by Its Cognate Enzyme Neutrophil Elastase in Sputum from Individuals with Cystic Fibrosis*
暂无分享,去创建一个
M. Butler | R. Levine | N. McElvaney | C. Greene | S. O’Neill | N. Guyot | C. Taggart | P. McNally | S. Weldon
[1] S. Tajima,et al. Accumulation of elafin in actinic elastosis of sun-damaged skin: elafin binds to elastin and prevents elastolytic degradation. , 2007, The Journal of investigative dermatology.
[2] M. Butler,et al. Elafin Prevents Lipopolysaccharide-induced AP-1 and NF-κB Activation via an Effect on the Ubiquitin-Proteasome Pathway* , 2006, Journal of Biological Chemistry.
[3] R. Levine,et al. Phosphorylation of actin Tyr-53 inhibits filament nucleation and elongation and destabilizes filaments , 2006, Proceedings of the National Academy of Sciences.
[4] M. Maurel,et al. Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase. , 2005, Biochemistry.
[5] N. McElvaney,et al. Elastolytic proteases: inflammation resolution and dysregulation in chronic infective lung disease. , 2005, American journal of respiratory and critical care medicine.
[6] T. Moreau,et al. Proteolytic susceptibility of the serine protease inhibitor trappin-2 (pre-elafin): evidence for tryptase-mediated generation of elafin , 2005, Biological chemistry.
[7] D. Look,et al. NF-kappaB activation and sustained IL-8 gene expression in primary cultures of cystic fibrosis airway epithelial cells stimulated with Pseudomonas aeruginosa. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[8] J. Sallenave,et al. The antimicrobial antiproteinase elafin binds to lipopolysaccharide and modulates macrophage responses. , 2005, American journal of respiratory cell and molecular biology.
[9] N. McElvaney,et al. Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. , 2004, The Journal of infectious diseases.
[10] R. Chaby. Lipopolysaccharide-binding molecules: transporters, blockers and sensors , 2004, Cellular and Molecular Life Sciences CMLS.
[11] C. Boudier,et al. Kinetics of the inhibition of neutrophil proteinases by recombinant elafin and pre-elafin (trappin-2) expressed in Pichia pastoris. , 2004, European journal of biochemistry.
[12] D. Webb,et al. Adenoviral Gene Delivery of Elafin and Secretory Leukocyte Protease Inhibitor Attenuates NF-κB-Dependent Inflammatory Responses of Human Endothelial Cells and Macrophages to Atherogenic Stimuli1 , 2004, The Journal of Immunology.
[13] P. C. White,et al. Supernatants of Pseudomonas aeruginosa induce the Pseudomonas‐specific antibiotic elafin in human keratinocytes , 2003, Experimental dermatology.
[14] R. Levine,et al. Inactivation of Human β-Defensins 2 and 3 by Elastolytic Cathepsins1 , 2003, The Journal of Immunology.
[15] J. Innes,et al. Airways in cystic fibrosis are acidified: detection by exhaled breath condensate , 2002, Thorax.
[16] Y. Bourbonnais,et al. Anti-Inflammatory Effect of Pre-Elafin in Lipopolysaccharide-Induced Acute Lung Inflammation , 2002, Biological chemistry.
[17] R. Levine,et al. Cathepsin B, L, and S Cleave and Inactivate Secretory Leucoprotease Inhibitor* , 2001, The Journal of Biological Chemistry.
[18] D. Porteous,et al. Regulation of adenovirus-mediated elafin transgene expression by bacterial lipopolysaccharide. , 2001, Human gene therapy.
[19] L. Bingle,et al. Cytokine-mediated induction of the human elafin gene in pulmonary epithelial cells is regulated by nuclear factor-kappaB. , 2001, American journal of respiratory cell and molecular biology.
[20] G. Tremblay,et al. Human Alveolar Macrophages Express Elafin and Secretory Leukocyte Protease Inhibitor , 2001, Zeitschrift fur Naturforschung. C, Journal of biosciences.
[21] C. Craik,et al. Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[22] C. Legrand,et al. Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase. , 2000, Thrombosis research.
[23] R. Pfundt,et al. TNF-α and serum induce SKALP/elafin gene expression in human keratinocytes by a p38 MAP kinase-dependent pathway , 2000, Archives of Dermatological Research.
[24] C. Haslett,et al. Human neutrophil elastase regulates the expression and secretion of elafin (elastase‐specific inhibitor) in type II alveolar epithelial cells , 1999, FEBS letters.
[25] C. Haslett,et al. Elafin (elastase‐specific inhibitor) has anti‐microbial activity against Gram‐positive and Gram‐negative respiratory pathogens , 1999, FEBS letters.
[26] J. Sallenave,et al. Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils , 1997, Journal of leukocyte biology.
[27] I. Pavord,et al. The use of induced sputum to investigate airway inflammation. , 1997, Thorax.
[28] G. Lippens,et al. Solution structure of R-elafin, a specific inhibitor of elastase. , 1997, Journal of molecular biology.
[29] R. Pfundt,et al. Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia. , 1996, The Journal of clinical investigation.
[30] Y. Katsube,et al. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution. , 1996, Biochemistry.
[31] E. Christophers,et al. Antiprotease activity in urine of patients with inflammatory skin disorders. , 1995, The Journal of investigative dermatology.
[32] P. Steinert,et al. The Proteins Elafin, Filaggrin, Keratin Intermediate Filaments, Loricrin, and Small Proline-rich Proteins 1 and 2 Are Isodipeptide Cross-linked Components of the Human Epidermal Cornified Cell Envelope (*) , 1995, The Journal of Biological Chemistry.
[33] M. Jordana,et al. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. , 1994, American journal of respiratory cell and molecular biology.
[34] M. Ponec,et al. SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes. , 1994, Journal of cell science.
[35] K. Yamanishi,et al. Up-regulation of elafin/SKALP gene expression in psoriatic epidermis. , 1994, The Journal of investigative dermatology.
[36] Y. Suzuki,et al. Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed "cementoin". , 1994, Journal of biochemistry.
[37] B. Doebbeling,et al. Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis , 1993, Infection and immunity.
[38] B. Wieringa,et al. SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking. , 1993, The Journal of biological chemistry.
[39] S. Simon,et al. Kinetics of the inhibition of human leukocyte elastase by elafin, a 6-kilodalton elastase-specific inhibitor from human skin. , 1993, Biochemistry.
[40] S. Sakakibara,et al. Synthesis and structure-activity relationships of elafin, an elastase-specific inhibitor. , 1992, Biochemical and biophysical research communications.
[41] A. Berger,et al. On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.
[42] N. McElvaney,et al. Interleukin-1, Neutrophil Elastase, and Lipopolysaccharide: Key Pro- Inflammatory Stimuli Regulating Inflammation in Cystic Fibrosis , 2005 .
[43] J. Schalkwijk,et al. Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[44] J. Sallenave,et al. Isolation of elafin and elastase-specific inhibitor (ESI) from bronchial secretions. Evidence of sequence homology and immunological cross-reactivity. , 1992, Biological chemistry Hoppe-Seyler.
[45] M. Metsis,et al. Transglutaminase-sensitive glutamine residues of human plasma fibronectin revealed by studying its proteolytic fragments. , 1986, European journal of biochemistry.
[46] A. Blow. Action of human lysosomal elastase on the oxidized B chain of insulin. , 1977, The Biochemical journal.